The Novel Applications and Cutting Edge Technologies for GPCR Screening and Profiling conference provides an opportunity to hear from thought leaders within this rapidly developing field.
The event will take place at The Nucleus conference centre, Chesterford Research Park, Saffron Walden, UK, from 22-23 September 2009.
Keynote speaker Fiona Marshall, chief scientific officer, Heptares Therapeutics, will talk about 'Structure-based Drug Discovery for GPCR Targets'.
The meeting will highlight the latest technological developments and tools available for drug discovery on GPCR receptors, with key opinion leaders presenting their experience of generating high-quality screening data.
Furthermore, case studies will be described where flexible assay formats and newly available tools have enhanced throughput for successful compound screening.
Delegates are encouraged to present posters.
The meeting is being sponsored by three companies involved in GPCR research: Biofocus DPI, DiscoverX and MDS Analytical Technologies.
Attendance is free but limited to 150 delegates.
